Halozyme Therapeutics, Inc. (HALO) Estimates

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Revenue Estimates

Metric Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Reported (Actual) 230.04 M195.88 M231.35 M290.08 M298.01 M264.86 M325.72 M354.26 M-----
High Estimate 233.65 M212.86 M204.82 M269.26 M324.81 M229.72 M316.13 M373.49 M444.73 M433.88 M444.53 M451.50 M505.17 M
Low Estimate 197.14 M176.52 M181.29 M221.59 M270.79 M205.16 M288.63 M327.90 M369.36 M355.87 M383.31 M414.84 M423.40 M
Consensus Estimate 215.39 M194.69 M193.06 M245.42 M297.80 M217.44 M302.38 M350.70 M407.05 M394.88 M413.92 M433.17 M464.29 M

Earnings Per Share (EPS) Estimates

Metric Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Reported (Actual) 0.820.790.911.271.261.111.541.72-----
High Estimate 0.880.710.751.021.181.041.371.742.061.972.182.312.49
Low Estimate 0.820.630.710.881.040.941.231.601.881.731.861.932.19
Consensus Estimate 0.850.670.730.951.110.991.301.671.971.852.022.122.34